Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jessica M Heijdra

7PUBLICATIONS
13CO-AUTHORS
HaematologyDevelopmental genetics (incl. sex determination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Oct 03, 2022
Desmopressin testing in von Willebrand disease: Lowering the burden.

Jessica M Heijdra, Ferdows Atiq, Wala Al Arashi

|May 08, 2022
Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study.

Jessica M Heijdra, Michael E Cloesmeijer, Nico C B de Jager

|Apr 21, 2022
Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease.

Ferdows Atiq, Jessica Heijdra, Fleur Snijders

|Feb 16, 2022
Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study.

Jessica M Heijdra, Wala Al Arashi, Nico C B de Jager

|Sep 27, 2019
One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P<sup>®</sup> /Humate P<sup>®</sup> treatment in von Willebrand disease patients.

Nico C B de Jager, Laura H Bukkems, Jessica M Heijdra

|Mar 25, 2018
Analysis of current perioperative management with Haemate<sup>®</sup> P/Humate P<sup>®</sup> in von Willebrand disease: Identifying the need for personalized treatment.

H C A M Hazendonk, J M Heijdra, N C B de Jager

Pageof 2

Frequent Collaborators

4 joint publications

Frank W G Leebeek

3 joint publications

Marjon H Cnossen

2 joint publications

Ferdows Atiq

2 joint publications

Karina Meijer

2 joint publications

Marieke J H A Kruip

1 joint publications

Eva Kempers

1 joint publications

Waander L van Heerde

1 joint publications

Selene C Schoormans

1 joint publications

Johanna G van der Bom

1 joint publications

Karin Fijnvandraat

Frequent Collaborators

4 joint publications

Frank W G Leebeek

3 joint publications

Marjon H Cnossen

2 joint publications

Ferdows Atiq

2 joint publications

Karina Meijer

Top Related Videos

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on : Aug 14, 2017

11.3K
See more related videos

Top Related Videos

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on : Aug 14, 2017

11.3K
See more related videos